Company Filing History:
Years Active: 2013-2019
Title: Innovations and Contributions of Inventor Kirk McMullin
Introduction
Kirk McMullin, an accomplished inventor based in Villa Park, California, has made significant contributions to the field of sterile product filling and ophthalmic formulations. With a total of three patents to his name, McMullin's innovations emphasize the importance of efficient design and practical application in pharmaceutical settings.
Latest Patents
Among his latest patents, McMullin has developed a "Portable, self-contained, ready-to-use, sterile enclosure for filling sterile products." This innovative enclosure is designed to facilitate the filling of small quantities of sterile products. It effectively integrates all necessary fittings and filters, allowing for remote sterilization using techniques such as gamma irradiation or ethylene oxide gas. The design of the enclosure not only ensures sterility during shipping but also allows end users to perform sterile filling without needing aseptic connections or further sterilization equipment.
Another pivotal invention by McMullin is the "Ophthalmic formulations and uses thereof." This patent outlines compositions suitable for treating eye conditions. It combines an ophthalmically-active antimicrobial agent with an anti-inflammatory or steroidal agent alongside physiologic levels of serum electrolytes, creating a formulation designed for effective application in treating various ophthalmic diseases, injuries, or disorders. Furthermore, this invention includes kits that facilitate the easy application of the compositions to patients’ eyes.
Career Highlights
Throughout his career, Kirk McMullin has collaborated with various companies, notably Ista Pharmaceuticals, Inc. His work in these companies highlights a dedication to advancing pharmaceutical technologies and improving patient care through innovative solutions.
Collaborations
Collaboration has played an essential role in McMullin's advancements. He has worked alongside esteemed professionals such as Mark Barry Abelson and Jasbir Dhanjal, contributing to a synergistic approach in developing effective medical formulations and technologies.
Conclusion
Kirk McMullin's innovative patents and collaborative efforts have significantly advanced the fields of sterile product filling and ophthalmic treatment formulations. His work not only reflects his ingenuity as an inventor but also underscores the importance of practical solutions in enhancing medical practices. As he continues to innovate, McMullin's contributions will likely influence the future of pharmaceuticals and patient care.